A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)

OBJECTIVES: Veliparib (V) potentiated therapeutic efficacy of cisplatin (C) and etoposide (E) in preclinical models of SCLC. We conducted this phase 1 study to establish the safety of the combination in human subjects. MATERIALS AND METHODS: The study employed the 3+3 dose escalation design to estab...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Lung Cancer
Autori principali: Owonikoko, Taofeek K., Dahlberg, Suzanne E., Khan, Saad A., Gerber, David E., Dowell, Jonathan, Moss, Rebecca A., Belani, Chandra P., Hann, Christine L., Aggarwal, Charu, Ramalingam, Suresh S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4539011/
https://ncbi.nlm.nih.gov/pubmed/25985977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2015.04.015
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi